enasidenib
FDA Issues Warning About Differentiation Syndrome With Two IDH Inhibitors
San Diego—The FDA issued a boxed warning for differentiation syndrome for two isocitrate dehydrogenase (IDH) ...
DECEMBER 13, 2018
FDA Approves Idhifa & RealTime IDH2 Assay for R/R AML
The FDA approved enasidenib (Idhifa, Celgene) to treat adult patients with relapsed or refractory AML who have the ...
AUGUST 3, 2017
Load more